PharmaTalkRadio
435 episodes - English - Latest episode: 17 days ago - ★★★★ - 16 ratingsPharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
What to Expect at Rational Combinations 360° 2018 - 5 Min Overview
July 19, 2018 16:30 - 6 minutes - 4.96 MBRational Combinations 360° addresses business aspects, clinical advancements and scientific data in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer. Rational Combinations 360° addresses the following plenary topics over t...
How to Innovate in the Drug Delivery Space
June 23, 2018 17:00 - 32 minutes - 29 MBHow to Innovate in the Drug Delivery Space What does the innovation process look likeThe barrier to the innovation process and how to overcomethemSummary of disease spaceGood design and engineering practicesHow to salvage something that goes wrong?How do you find the unknown unknowns?Does it feel right? Uri Baruch Head of Drug Delivery, Cambridge Design Partnership This talk was given at the 2018 Drug Delivery West Meeting.
Key Trends in Drug Delivery: Expert Perspective
June 23, 2018 13:00 - 34 minutes - 30.7 MBOpening talk at Drug Delivery West, 2018 Key Trends in Drug Delivery: Expert Perspective Randall Mrsny, PhD Professor's Chair, Department of Pharmacy and Pharmacology, University of Bath
How FARA and Horizon Pharma Partnered to Improve Clinical Development
June 22, 2018 15:00 - 34 minutes - 30.4 MBPatients as Partners Day 2 Session How FARA and Horizon Pharma Partnered to Improve Clinical Development and Trial Design-Case Study This session will feature how the Friedreich’s Ataxia Research Foundation collaborated with Horizon Pharma on aspects of clinical development and trial design to better understand patients living with the disease and how to better develop medicine to help manage their disease. Key areas of discussion include how they collaborated on the following: • Focus gro...
How Takeda Used One or More of the Various Patient Engagement Frameworks
June 22, 2018 14:30 - 25 minutes - 22.1 MBThis talk was given at the Patients as Partners 2018 Meeting There are many frameworks and models that exist from various organizations on aspects of patient engagement and may be challenging to navigate through when applying to your own initiatives. In this session, Takeda will walk the audience through how they used multiple patient engagement frameworks to create an internal R&D Patient Engagement Guide tailored for their drug development teams from discovery through marketed products. Th...
How Patient Research Advocates are Driving R&D: A Patient Case Study
June 21, 2018 16:00 - 27 minutes - 24.1 MBThis talk was given at the Patients as Partners 2018 Meeting How Patient Research Advocates are Driving R&D: A Patient Case Study In this session, patient and research advocate, Geraldine Blavat will walk the audience through 10 steps on how patient input is integrated through the entire clinical development continuum including: Developing the Study Concept Secure Funding Preparing the Study Protocol Creating Study Procedure Implementing the Study Monitoring the Study Analyzing the ...
Fireside Chat: Lessons Learned from a Drug Delivery Pioneer and Risk-Taker
June 21, 2018 14:30 - 40 minutes - 35.9 MBJohn Patton, PhD, Chief Executive Officer and Chairman with Dance Biopharma and Ann Daugherty, PhD, Senior Manager, Drug Delivery with Genentech present the closing talk at Drug Delivery West, held May 21-22, 2018 in San Francisco. In this talk they discuss the lessons learned from drug delivery, what to be aware of in the future, and how to improve drug delivery methods. The next conference in Drug Delivery is the 8th annual PODD: Partnership Opportunities in Drug Delivery on October 17-18...
Nanotechnology Keynote
June 07, 2018 20:00 - 33 minutes - 29.7 MBNanotechnology Keynote Address given by Omid Farokhzad, MD, Professor, Harvard Medical School and Director, Center for Nanomedicine, Brigham and Women's Hospital Omid Farokhzad is an inventor of more than 145 issued / pending patents. These for the launch of four biotechnology companies: BIND Therapeutics (acquired by Pfizer) Selecta Biosciences, Tarveda Therapeutics (formerly Blend Therapeutics) and Placon Therapeutics (spin-out from Tarveda), which are translating the aforementioned academ...
Utilizing a Device Platform Technology across Multiple Therapeutic Categories
June 07, 2018 17:00 - 36 minutes - 32.7 MBPanel: Utilizing a Device Platform Technology across Multiple Therapeutic Categories Most pharma and biotech companies realize the need and benefit of having a platform device technology. The challenge then becomes figuring out how to utilize the device to deliver different types of drugs for various indications such as rheumatoid arthritis, cancer, and rare diseases. Moderator: Paul Jansen Former Associate VP Sanofi and Board Member and Senior Advisor, Haselmeier Panelists: Donna Frenc...
CEO Keynote Fireside Chat
June 06, 2018 14:00 - 40 minutes - 36.5 MBThe Keynote was given at Partnerships Opportunities in Drug Delivery 2017 by Lars Rebein Sorensen Former President and CEO, Novo Nordisk with Barbara Lueckel, PhD Global Business Development Director Roche Partnering Innovation, Roche
Addressing R&D Challenges using Drug Delivery Technologies
June 05, 2018 19:30 - 45 minutes - 40.8 MBThe expert panel of scientific leaders from industry will discuss current formulation and delivery challenges for therapeutic areas (ophthalmology, immunology, oncology infectious disease, and neurodegenerative area disorders). Each panelist will address a specific disease area and discuss the role of drug delivery in the treatment of disease. The panel will also cover currently available delivery technologies and where improvement is needed. Moderator: Ann Daugherty, PhD Senior Manager, D...
Panel: Hitting the "Reset" Button on Direct-to-CNS Delivery
June 04, 2018 18:00 - 50 minutes - 45.2 MBThe expert panel will address the scientific and business challenges and opportunities in this space. Panelists will discuss the difficult nature of providing therapies for diseases of the CNS, covering both device and chemistry-enabled technologies. They will also address questions such as: Can devices take us where chemistry has not?What advances being made in the field of chemis conjugation technologies?Why is intrathecal, intracerebroventricular and intraparenchymal delivery relevant for...
Current and Emerging Drug Delivery Needs in Oncology
June 04, 2018 15:00 - 59 minutes - 53.1 MBDrug Delivery Needs in Oncology Due to the increasing number of parenteral biologic therapies that are administered intravenously, the already high pressure on infusion capacity and healthcare resources is expected further increase. A change from intravenous to subcutaneous dosing has been shown to reduce dosing complexity and overall drug administration related costs. There is keen interest in technologies that facilitate subcutaneous administration and potentially enable drug administratio...
Building Blocks of IO Clinical Trials - Part 2
May 11, 2018 13:30 - 50 minutes - 45 MBTrack 2: Clinical Operations for IO Trials This section is designed for clinical trial operation executives who want to learn what it takes to execute an IO clinical trial. This is an excellent opportunity to walk through the building blocks of IO clinical trial operations and discuss pitfalls and lessons learned. Plenary Chair: Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck This discussion was presented at the 2018 Immuno-Oncology 360° Meeting.
Building Blocks of IO Clinical Trials - Part 1
May 10, 2018 13:30 - 1 hour - 76.8 MBBuilding Blocks of IO Trials: This talk will consist of 7 perspectives that identify operational aspects of IO trials, including a patient perspective, site management, 3rd party component, clinical supply chain, a PI perspective, data management and project management. The collaborative talk concludes with a panel discussion and Q&A. This Discussion was presented at the 2018 Immuno-Oncology 360° Meeting.
Endpoints News Industry Report on IO Collaborations and Trends
May 09, 2018 13:30 - 15 minutes - 13.1 MBEndpoints News Industry Report on IO Collaborations and Trends In this episode of Pharma Talk Radio, John Carroll, Editor-in-Chief of Endpoints News, reviewed the build up of the immuno-oncology space over the past few years at the IO360° conference that took place February 2018. Mr Carroll discussed the impact the large amount of money and the extraordinary numbers that have been invested in the space, have had on collaborations. He also shed light on the natural limitations and boundaries ...
CTTI Report - Mobile Clinical Trials Program: Recommendations on Novel Endpoints
April 30, 2018 04:00 - 23 minutes - 20.4 MBMobile Podcast Series #2 CTTI Findings are in from their Mobile Clinical Trials Program: Recommendations on Novel Endpoints CTTI's Mobile in Clinical Trials program was launched three years ago to propose recommendations that clarify the pathway for developing novel endpoints for use in clinical trials from data generated using mobile technology. Jennifer Goldsack shares recommendations and insights from their findings on: Developing an internal process for identifying endpointsStrategies f...
How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes
April 29, 2018 13:00 - 18 minutes - 16.3 MBPodcast on Mobile in Clinical Trials Series #1 How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes Crescendo Biosciences's CIO, Alex Bangs, reports on how a human-centered design approach was used to create MyRA, an award-winning app for patients living with RA. This podcast comes from the 2017 Mobile in Clinical Trials US event. The next Mobile in Clinical Trials conference is May 15-16 in London and then September 24 in Boston. Mobile is the annual update on n...
Lessons Learned from the Journey of a CMO Leader, Michael Rosenblatt, MD
April 18, 2018 12:00 - 45 minutes - 41.1 MBThe Chief Medical Officer Summit is delighted to present a podcast featuring the Keynote Fireside Chat with Michael Rosenblatt, MD, on Lessons Learned from the Journey of a CMO Leader In this session, Dr Rosenblatt, former Merck CMO, will share his insights on career path decision-making and will compare the experiences and lessons learned from being the CMO on the drug development side versus the biotech investor side of the industry. Moderated by CEO of Evelo Biosciences, Simba Gill, MBA, ...
Developing a Pathway for Compassionate Use Cases
April 17, 2018 19:30 - 46 minutes - 42 MBThe Chief Medical Officer Summit is delighted to share a podcast featuring a presentation prepared by Drs Alison Bateman-House and Arthur Caplan of NYU's Division of Medical Ethics on the topic of: Developing a Pathway for Compassionate Use Cases What should the CMO do when they receive a request?What's the role of the CMO, the FDA and the IRB?Lessons learned from Janssen Case StudyHow do you scale down for a biotech?Potential modelsCan the process be accelerated? Join us at the 6th annual...
2018 Chief Medical Officer Summit Podcast Overview in a Nutshell
April 17, 2018 14:30 - 7 minutes - 6.39 MBThis podcasts gives you an overview on what to expect for the 2018 Chief Medical Officer Summit in a nutshell. The concept of the CMO Summit came from MPM Capital’s Dr Elizabeth Stoner, who told us that there is a deep need for a Summit that is designed for CMOs and heads of R&D in the emerging biotech space, specifically, where we can cover all the key issues affecting R&D decisions together with business development issues. The program takes place on May 7th and 8th at the Omni Parker House...
Clinical Research as a Care Option, 2nd annual - 3 min Podcast Overview
March 04, 2018 07:00 - 4 minutes - 2.99 MBIn this three minute podcast, you get an overview of one of the hottest topics we are covering in a full day 2nd annual event on Clinical Research as a Care Option. (CRAACO). Making clinical trials a care option is arguably the greatest challenge we can collaborate on in bringing patients closer to clinical trials. CRAACO takes place on April 11th at the Boston Marriott Cambridge. We look at how to integrate clinical research into the overall continuum of patient care and ask, how do we make ...
What to Expect at Clinical Trial Collaborations 2018 – 5 min Podcast
March 04, 2018 05:30 - 5 minutes - 4.49 MBThis podcast gives you a five minute overview of the 3rd annual Clinical Trial Collaborations conference, otherwise known as CTC. CTC is a strategic level event focused on arguably the most important change in transforming drug development: How and who we collaborate with to drive better clinical trial outcomes? CTC is ideal for people working in clinical trial operations, who are involved with external relationships or need to be involved with external relationships and want to see example...
Mobile in Clinical Trials Europe New for 2018 - 4 min Podcast Overview
March 01, 2018 17:30 - 4 minutes - 3.58 MBThe Mobile in Clinical Trials conference comes to Europe for the first time on May 15th and 16th at the Millennium Gloucester Hotel in London. If you work or want to work with mobile and digital technologies to make clinical trials more efficient and reduce patient burden, we highly recommend this conference for you. Using our past four years of experience in the US, we are able to combine the best examples of mobile and digital optimization in clinical trials from the US with examples from t...
Patients, a Seat at the Table in Clinical Trials with Pfizer’s Dr Roz Schneider
March 01, 2018 05:30 - 17 minutes - 15 MBDr Roslyn Schneider, Global Patient Affairs Lead at Pfizer, speaks with Valerie Bowling, Executive Director, Patients as Partners, in a podcast interview on patients at the center of clinical research. Dr Schneider, better known as Roz, helps drive patient centricity and the integration of the patiemt voice throughout the development of medicines at Pfizer. She gives us a brief history of the evolution of the involvement of patients in clinical research, next steps, and how patients and indus...
Reducing the Burden of Type 1 Diabetes with Patient Dana Lewis:DPharm Podcast #5
February 19, 2018 16:00 - 28 minutes - 25.4 MBDPharm Podcast Series #5 Reducing the Burden of Type 1 Diabetes through a Model of Democratized R&D Patient advocate star, Dana Lewis, founder of OpenAPS delivers a powerful session at DPharm on an idea to reduce the burden of type 1 diabetes with a smart system she created through open soucre. Learn how she drive the idea and creation of the "Self driving car for diabetes". The next DPharm conference is September 25-26 in Boston. DPharm reports on innovation and disruptive innovation to a...
5th Annual Patients as Partners What to Expect Overview Podcast in 7 Minutes
February 19, 2018 01:00 - 8 minutes - 6.48 MB5th Annual Patients as Partners What to Expect Overview Podcast Officially approved by Patients Included, Patients as Partners is the only program in the US that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. Taking place March 15-16 in Philadelphia, the focus of this year’s program is on turning discussion into action, and Kate Woda, the Conference Director has worked meticulously with th...
Wireless Remote Monitoring – DPharm Podcast Series #2
February 17, 2018 15:00 - 30 minutes - 26.6 MBDPharm podcast series # 2 MIT Professor, Dina Katabi, PhD gave one of the best talks on in home non-intrusive patient monitoring at DPharm 2017 and provided a demo of technology that uses ambient radio signals to monitor a patient’s gait, falls, breathing, heart rate and even sleep, all without putting any sensor on the patient’s body. Find out how they have used the technology to redefine clinical endpoints and pushed clinical trials to the home. The next DPharm conference is September 25-...
Immuno-Oncology Clinical Trial Operations 4 Min Summary of What to Expect
January 28, 2018 16:30 - 5 minutes - 3.74 MBThe Conference Forum presents a 1 day meeting on Immuno-Oncology Clinical Trial Operations, February 8th at the Roosevelt hotel in NYC. It’s part of the IO360 conference, which runs over three days from Feb 7th through the 9th. The OPERATIONS portion of this conference is offered as a stand alone program. This podcast gives a brief summary of what to expect. The morning provides first hand reporting on new trends and emerging technologies. The afternoon goes through 7 components including:...
Patients as Partners EU Overview in 3 Minutes
December 27, 2017 05:30 - 4 minutes - 2.8 MBThe 2nd annual Patients as Partners EU is the only conference in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. In this short podcast, Valerie Bowling, executive director at the Conference Forum gives a brief summary of what to expect at this conference and runs through the highlights. Chairs: Tony Hoos, MD, PhD, MBA Head of Medical, Amgen Europe Andrew Garvey Global Patient Advoca...
Roche's Dr Barbara Lueckel Reviews the 2016 Drug Delivery Industry
September 26, 2017 19:00 - 26 minutes - 23.1 MBIf you are interested in hearing the 2017 drug delivery landscape year in review in 2017, please email [email protected] Chair of the Partnership Opportunities in Drug Delivery (PODD) event, Dr Barbara Lueckel, Head of Research and Technologies Partnering at Roche, presents an annual year-in-review of the drug delivery landscape from 2016. Dr Lueckel’s opening remarks are a highlight of PODD every year, and we’re excited to have her return as program chair for the 2018 event, coming up on O...
From the Olympics to Clinical Research
September 22, 2017 17:30 - 20 minutes - 17.9 MBPan American Games Champion, Olympian and World Championship silver medalist, Jennifer Goldsack, became a world-class athlete while working and studying at the University of Oxford. How did she do it? She recently shared her story with DPharm Director, Valerie Bowling, discussing the lessons she learned from her Olympic experience and how she uses them in her professional life at the Clinical Trials Transformation Initiative (CTTI). Ms Goldsack manages the development and implementation of C...
What to Expect at Immuno-Oncology 360° 2018
September 20, 2017 15:00 - 7 minutes - 5.91 MBImmuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including: Discovery / Preclinical ScienceTranslational ScienceClinical DevelopmentBusiness AspectsInvestor RelationsEmerging TechnologiesBiomarkers / DiagnosticsTrends in the Field Dr Axel Hoos, GSK and Dr James Gulley, NCI, together led the design of the 4th annual Immuno-Oncology 360° program to include 45 speakers and over 30 talks. Save the date: ...
Why Pharma R&D has to Start Thinking Like a Service Industry and How?
August 24, 2017 23:30 - 48 minutes - 43.7 MBThe Conference Forum is pleased to share a podcast featuring keynote speaker and world renowned customer service expert, Dr Chip Bell who spoke at the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on the topic of service in clinical trials. To truly service our patients, we need to understand service together with science. Can service be a disrupter in clinical research? In this keynote, Dr Bell tells us how to think like a service industry, why it’s worth it for R&D a...
The Gap Between Clinical Care, Patient Involvement & What Patients Want
June 27, 2017 15:00 - 52 minutes - 47.1 MBOriginally recorded during the 4th annual Patients as Partners US event held in Philadelphia, March 2017, Bristol-Myers Squibb’s Mary Stober-Murray moderates this multi-stakeholder panel to discuss what patients truly want when it comes to clinical care and patient involvement. Patients John Creveling, a Parkinson’s Foundation Research Advocate, and Deb Maskens from the International Kidney Cancer Coalition, join her and representing the industry perspective are Paul Graves from Takeda Pharma...
Digital Solutions Impacting the Economic Efficacy of Clinical Trials
June 26, 2017 15:00 - 45 minutes - 40.7 MBInternationally recognized digital health expert, Donald Jones, MBA, Chief Digital Officer at Scripps Translational Science Institute, shares his insights on the digital clinical trial landscape and the urgent need to pair digitization with drug products for patients during his keynote address from the 2016 CMO Summit. The Chief Medical Officer Summit is designed for CMOs and R&D Leadership from small to mid-size life science companies. The 6th Annual CMO Summit will be held May 7-8, 2018, i...
Partnering with Patient Organizations for Advancing Cures
June 23, 2017 18:30 - 42 minutes - 37.7 MBIn this multi-stakeholder session from the 4th annual Patients as Partners US meeting, patients, advocates, industry and nonprofit organizations come together to discuss how they partnered and the outcomes of those partnerships. • What’s the roadmap? • What are the ways you have partnered with industry? • What are some best practices or rules of engagement? • How can the pharma industry better serve patient advocacy organizations? • How are we creating and ruthlessly maintaining transpar...
Challenges and Opportunities in Pursuing a New Therapeutic Modality
June 23, 2017 15:00 - 37 minutes - 33.9 MBAdapted from the 2016 Chief Medical Officer Summit keynote address, Dr Akshay Vaishnaw, who serves as EVP of R&D and CMO at Alnylam Pharmaceuticals, tackles the challenges and opportunities in pursuing a new therapeutic modality from its inception. The Chief Medical Officer Summit is designed for CMOs and R&D Leadership from small to mid-size life science companies. The 6th Annual CMO Summit will be held May 7-8, 2018, in Boston.
Partnering with Patients in the Development and Lifecycle of Medicines
June 22, 2017 17:30 - 37 minutes - 33.1 MBAt the 2017 Partners Europe event in London, Nicholas Brooke, Chief Executive, Patient Focused Medicines Development (PFMD) and Jan Geissler, Director, European Patients’ Academy on Therapeutic Innovation (EUPATI) call on industry to partner with patients in the development and lifecycle of medicines. The Patients as Partners Europe program seeks to understand and incorporate the patient's voice in designing clinical trials and developing a clinical endpoint, as well as vastly improve the pa...
Trends and Collaborations in the IO Space
June 22, 2017 15:00 - 42 minutes - 38.4 MBDr Axel Hoos, GSK, leads a panel discussion on Trends and Collaborations in the Immuno-Oncology Space, featuring Dr Ramy Ibrahim, VP and Head of R&D, Parker Institute for Cancer Immunotherapy; Dr Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs, Cancer Research Institute; Dr Daniel Chen, VP, Global Head of Cancer Immunotherapy Development, Genentech; and David Wholley, MPhil, Director, Research Partnerships Division, Foundation for the National Institutes of Health. The 4th Annu...
Unlocking the Power of Patient Engagement within Clinical and Commercial
June 21, 2017 18:00 - 12 minutes - 11 MBAt the inaugural Patients as Partners Europe event, Duncan Arbour from inVentiv Health explores the ‘how’ and ‘when’ for involving patients within clinical and commercial to enhance the development and delivery of innovative therapies. The patient voice as a strategic driver is being included much earlier in the development process than ever before. In this session, pharmaceutical, biotech and device companies will gain insight into the value of smarter patient integration. Key focus areas ...
Patients Influencing Policy in the EU
June 21, 2017 16:00 - 31 minutes - 28.2 MBAlastair Kent, Director of the Genetic Alliance UK, talks about how patients can and are influencing policy within the EU. The Patients as Partners Europe program seeks to understand and incorporate the patient's voice in designing clinical trials and developing a clinical endpoint, as well as vastly improve the patient's entire experience in a clinical trial. The 2nd annual Patients as Partners EU event will be held January 23-24, 2018 at Radisson Blu Portman Hotel, London, UK.
Immuno-Oncology 360°: Business Models for Complex Science by Dr Axel Hoos of GSK
June 21, 2017 15:00 - 25 minutes - 22.5 MBOriginally presented during the business aspects plenary session at Immuno-Oncology 360° 2017, Dr Axel Hoos of GSK discusses business models for complex science. Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in New York City. Dr Hoos returns as lead advisor, as well as moderating a talk called, "Investor Roundtable: The Role of IO within Large Pharma - Where Does it Stand?" with panelists from Citi, Atlas Venture, New Enterprise Associates, and SR One L...
Increasingly Critical Role of Predictive Biomarkers in Cancer Immunotherapy
June 20, 2017 15:30 - 23 minutes - 20.3 MBChief Medical Officer at nanoString Technologies, Dr Alessandra Cesano, brings to light the increasingly critical role of predictive biomarkers in cancer immunotherapy, originally presented during the translational science and new technologies session from 2017’s Immuno-Oncology 360° conference. Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in New York City. About Dr Cesano: Alessandra Cesano, MD, PhD has served as CMO at nanoString since July 2015. Pr...
Innovative Ways of Patient Involvement in Medicines Development
June 20, 2017 15:00 - 54 minutes - 49.4 MBOriginally recorded at the inaugural Patients as Partners Europe event, held in London in February 2017. Patient, industry, and regulatory perspectives are provided by Alastair Kent of Genetic Alliance UK, Dr Anton Hoos of Amgen Europe, and Isabelle Moulon of the EMD as they discuss on innovative ways of to include patient involvement in medicines development. The Patients as Partners Europe program seeks to understand and incorporate the patient's voice in designing clinical trials and deve...
Important Business Aspects of Immuno-Oncology: Issues and Controversies
June 20, 2017 15:00 - 45 minutes - 40.5 MBOriginally recorded during a panel session at the 2017's Immuno-Oncology 360°, Mark Simon of Torreya Partners moderates the conversation around issues, controversies, and other important business aspects of IO. He's joined by IO360° lead advisor and SVP at GSK, Dr Axel Hoos, Dr Robert Ang of Neon Therapeutics, Dr Jeffrey Bockman from Defined Health, Dr Jeffrey Legos from Novartis Pharmaceuticals, and Dr Chandra Ramanathan at Bayer Healthcare. Save the date for the 4th annual IO360° conferenc...
Addressing Clinical Challenges in Immuno-Oncology
June 20, 2017 15:00 - 47 minutes - 42.4 MBOriginally recorded during the 3rd annual Immuno-Oncology 360° in February 2017, this panel discussion addresses clinical challenges within immuno-oncology. One of the IO360° lead advisors, Dr James Gulley of the National Cancer Institute, moderates the session between Merck’s Dr Roy Baynes, nanoString Technologies’ Dr Alessandra Cesano, MD Anderson’s Dr Patrick Hwu, and inVentiv Health’s Robert Millham. Dr Hwu and Dr Baynes are also speaking on the 2nd annual Rational Combinations 360° prog...
Sequencing of Combination Agents in Immuno-Oncology with Dr Charles Drake
June 16, 2017 17:00 - 20 minutes - 17.7 MBDuring the preclinical science plenary session from 2017's Immuno-Oncology 360° conference, Dr Charles Drake's talks about "Sequencing of Combination Agents." Dr Drake is Director, Genitourinary Oncology and Co-Director Immunotherapy Associate Director, Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center. Previously, he was an associate professor of oncology, urology and immunology at the Johns Hopkins School of Medicine. He also serves as Co-Director of the Pro...
Next Generation of Combination Immunotherapy with Dr Patrick Hwu of MD Anderson
June 07, 2017 19:30 - 33 minutes - 29.4 MBAt 2016's Rational Combinations 360° meeting, Dr Patrick Hwu of MD Anderson Cancer Center delivered a keynote address on the future outlook behind combination immunotherapy. Dr Hwu addresses innovations behind combination therapy, specifically focusing on what’s next after checkpoint combinations and whether combination of adoptive T-cell therapy and anti-checkpoint inhibitor therapies are the next wave. Dr Hwu serves as a lead advisor for the 2nd annual Rational Combinations 360° meeting, w...
5 Minute Overview of DPharm (Disrupting Clinical Trials) Europe: What to Expect?
January 26, 2017 05:00 - 6 minutes - 5.13 MBThe 3rd annual DPharm Europe: Disruptive Innovations to Advance Clinical Trials event is led by Co-Chairs Dr Sue Collier (GSK) and Dr Jeff Kasher (Patients Can’t Wait). This radio blogcast gives a five minute overview of the event, which presents global case studies on: Real World Clinical Trial Strategies and ResultsNew Leadership in Driving Clinical Trial InnovationStrategies to Validate the Siteless TrialCommunity Outreach and Education in Clinical TrialsNew Financial ModelsPatient Involv...